Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL) - Barrera, C M; Mykietiuk, A; Metev, H (Lancet Infect Dis, 2016)
. doi:10.1016/s1473-3099(16)00017-7